GROCH JAMES R
Known title: DirectorCIK: 0001185424
GROCH JAMES R's purchase track record
GROCH JAMES R has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/18/2026 | WEX | $214K | +32.5% | pending | — |
| 8/17/2023 | WEX | $252K | -5.4% | +22.8% | +15.1% |
| 11/3/2022 | WEX | $212K | +27.2% | +13.1% | +9.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| WEX | ▲ Buy | Grant | 186 | — | 6/30/2026 | View on chart |
| WEX | ▲ Buy | Open Market | 1,500 | $214K | 5/18/2026 | View on chart |
| WEX | ▲ Buy | Option Exercise | 1,567 | $0 | 5/15/2026 | View on chart |
| WEX | ▲ Buy | Grant | 171 | — | 3/31/2026 | View on chart |
| WEX | ▲ Buy | Grant | 176 | — | 12/31/2025 | View on chart |
| WEX | ▲ Buy | Grant | 166 | — | 9/30/2025 | View on chart |
| WEX | ▲ Buy | Grant | 178 | — | 6/30/2025 | View on chart |
| WEX | ▲ Buy | Option Exercise | 960 | $0 | 5/9/2025 | View on chart |
| WEX | ▲ Buy | Grant | 167 | — | 4/8/2025 | View on chart |
| WEX | ▲ Buy | Grant | 149 | — | 1/7/2025 | View on chart |
| WEX | ▲ Buy | Grant | 125 | — | 10/4/2024 | View on chart |
| WEX | ▲ Buy | Grant | 136 | — | 7/3/2024 | View on chart |
| WEX | ▲ Buy | Option Exercise | 1,147 | $0 | 5/11/2024 | View on chart |
| WEX | ▲ Buy | Grant | 89 | — | 4/4/2024 | View on chart |
| WEX | ▲ Buy | Grant | 109 | — | 1/23/2024 | View on chart |
| WEX | ▲ Buy | Grant | 112 | — | 10/13/2023 | View on chart |
| WEX | ▲ Buy | Open Market | 1,350 | $252K | 8/17/2023 | View on chart |
| WEX | ▲ Buy | Grant | 116 | — | 7/13/2023 | View on chart |
| WEX | ▲ Buy | Option Exercise | 1,030 | $0 | 5/12/2023 | View on chart |
| WEX | ▲ Buy | Grant | 115 | — | 4/11/2023 | View on chart |
| WEX | ▲ Buy | Grant | 129 | — | 1/10/2023 | View on chart |
| WEX | ▲ Buy | Open Market | 1,400 | $212K | 11/3/2022 | View on chart |
| WEX | ▲ Buy | Grant | 167 | — | 10/11/2022 | View on chart |
| WEX | ▲ Buy | Grant | 136 | — | 7/15/2022 | View on chart |
| WEX | ▲ Buy | Option Exercise | 760 | $0 | 6/4/2022 | View on chart |
| WEX | ▲ Buy | Grant | 119 | — | 4/15/2022 | View on chart |
| WEX | ▲ Buy | Grant | 151 | — | 1/13/2022 | View on chart |
| WEX | ▲ Buy | Grant | 120 | — | 10/12/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
WEX Shares Stretch as Company Expands AI Claims Tool
WEX is expanding its AI claims tool, a move that has pushed the stock higher but also stretched its valuation. The shares are trading near the $148.41 support level, which has been tested 10 times. Investors are watching how the new AI features will impact the company’s earnings and pricing.
WEX Shares Stretch as Company Expands AI Claims Tool. WEX is expanding its AI claims tool, a move that has pushed the stock higher but also stretched its valuation. The shares are trading near the $148.41 support level, which has been tested 10 times. Investors are watching how the new AI features will impact the company’s earnings and pricing.